Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06075589 · ClinicalTrials.gov registry record · NA
Psychoeducation for Uveal Melanoma
A NA study of Uveal Melanoma, sponsored by Jonsson Comprehensive Cancer Center.
- Active
- Registry status
- NA
- Development phase
- 108
- Enrollment target
- 1
- Study location
NCT06075589 is a NA study of Uveal Melanoma that is active but no longer recruiting, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 108 participants, below the 141-participant average among 29 other Uveal Melanoma trials with a reported enrollment target (23% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06075589, a NA study of Uveal Melanoma, is active but no longer recruiting, sponsored by Jonsson Comprehensive Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 108 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual metastasis of the cancer. Learning about patients' thoughts and reactions to informational resources may better support patients during ocular melanoma survivorship.
Conditions Studied
Interventions
- BEHAVIORAL Education for Intervention
- BEHAVIORAL Best Practice
Study Locations (1)
California
- University of California at Los Angeles - Los Angeles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 108 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2027-12-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06075589
The ClinicalTrials.gov registry entry for NCT06075589 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 108 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 29 other Uveal Melanoma trials with a reported enrollment target (23% lower). The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Uveal Melanoma appearing as the primary indexed condition, and to 2 interventions - of which Education for Intervention is the first listed.
NCT06075589 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT06075589 about?
NCT06075589 is a clinical study titled "Psychoeducation for Uveal Melanoma". This clinical trial evaluates a video-based psychoeducational intervention for patients with uveal melanoma. Uveal melanoma (UM) is a rare intraocular cancer. UM patients face an uncertain course of survivorship in terms of their visual acuity, treatment-related side effects, and risk for eventual m...
What is the current status of trial NCT06075589?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 108 participants. The study started on 2023-11-07. Estimated completion is 2027-12-01.
What conditions does trial NCT06075589 study?
This clinical trial studies the following conditions: Uveal Melanoma.
What interventions are being tested in trial NCT06075589?
The interventions under investigation include: Education for Intervention (BEHAVIORAL), Best Practice (BEHAVIORAL).
Who is sponsoring clinical trial NCT06075589?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06075589 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Uveal Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Immune Response to Percutaneous Hepatic Perfusion With Melphalan for Ocular Melanoma Metastatic to the Liver
RECRUITING · NA
-
A Study of Concurrent Stereotactic Body Radiotherapy With Opdualag in Metastatic Uveal Melanoma
RECRUITING · Phase 2
-
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
RECRUITING · Phase 2
-
A Study of LN-144 or LN-145 in People With Advanced Uveal Melanoma, Undifferentiated Pleomorphic Sarcoma, or Dedifferentiated Liposarcoma
RECRUITING · Phase 1
-
Tebentafusp in HLA-A*0201 Positive Previously Untreated Metastatic Uveal Melanoma
RECRUITING · Phase 2
-
A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.